Partner Article
North East drug firm goes international
A Prudhoe-based drug maker has won a contract with one of the world’s leading pharmaceutical companies.
SCM Pharma has been asked by Sanofi-aventis to handle a new trial cancer drug in their specialised sterile facilities. SCM will work with the multi-national drugs company for three months, and will be making the drug before packaging it off to Sanofi-aventis for trails in Europe.
Shirley Dann, SCM Pharma’s Managing Director, said: “We are very pleased to be working with Sanofi-aventis on such an innovative project.
“The requirements fit very well with our strengths of handling such products and utilising our specialist sterile manufacturing capabilities.
“This particular project is also a triumph for the North East’s pharmaceutical sector with one of the bigger players like Sanofi-aventis collaborating with a smaller niche firm like ourselves.”
The drug will be given a radioactive ‘tag’ that SCM Pharma will develop into a suitable dosage so Sanofi-aventis can trace the effect the drug has on the body during its clinical trials.
The head if production at Sanofi Aventis said: “Due to the nature of this specific product, we required a specialist manufacturing partner, ideally in the UK.
“It seemed the ideal opportunity to work with a local partner the help us deliver this key stage of the overall project.”
This was posted in Bdaily's Members' News section by Ruth Mitchell .
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular morning National email for free.
Culture is the foundation for sustainable growth
Business must help young people take root in work
Purposeful procurement for long-term growth
Time to rethink outdated views on apprenticeships
The scale-ups rocketing through our fast world
Care about the experience, not just the outcome
The rise of an alternative investor model
Bots don't beat personal business coaching
From COVID-19 to the Middle East crisis
How to build credibility in B2B marketing
Is your business ready for the trade union change?
Government 'must take its foot off businesses' throats'